US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 17, 2020 (6 years ago)

Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline

What was recalled

Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059, NDC 69097-527-34

Recalling firm
Cipla
NDC code
69097-527-34
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0181-2021

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Magnesium recalls

See all